Karl Deacon

760 total citations
13 papers, 668 citations indexed

About

Karl Deacon is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Karl Deacon has authored 13 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Karl Deacon's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Melanoma and MAPK Pathways (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Karl Deacon is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Melanoma and MAPK Pathways (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Karl Deacon collaborates with scholars based in United Kingdom and United States. Karl Deacon's co-authors include Jonathan L. Blank, Alan J. Knox, Pratibha Mistry, Rachel L. Clifford, Jonathan Chernoff, R. M. Patel, Rajni V. Patel, Sharad Mistry, Susan A. Watson and Rajendra Kumari and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Molecular Biology of the Cell.

In The Last Decade

Karl Deacon

13 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Deacon United Kingdom 12 431 127 115 103 87 13 668
Delphine Gitenay France 16 455 1.1× 155 1.2× 142 1.2× 111 1.1× 127 1.5× 22 761
Hong-Duck Um South Korea 12 486 1.1× 141 1.1× 107 0.9× 67 0.7× 64 0.7× 17 712
Eva Besemfelder Germany 12 461 1.1× 186 1.5× 144 1.3× 141 1.4× 47 0.5× 12 870
Angela Iervolino Italy 9 566 1.3× 126 1.0× 163 1.4× 99 1.0× 86 1.0× 10 987
Tomoyuki Nakano Japan 18 591 1.4× 88 0.7× 107 0.9× 88 0.9× 107 1.2× 54 843
Anna Smith United States 14 600 1.4× 192 1.5× 191 1.7× 135 1.3× 76 0.9× 22 905
Chiya Kosaka Japan 16 488 1.1× 151 1.2× 126 1.1× 129 1.3× 140 1.6× 28 779
Virginia Novaro Argentina 19 375 0.9× 246 1.9× 135 1.2× 102 1.0× 118 1.4× 42 907
Robert V. Martinez United States 14 524 1.2× 206 1.6× 113 1.0× 107 1.0× 90 1.0× 22 901
Rangasudhagar Radhakrishnan United States 13 424 1.0× 123 1.0× 158 1.4× 75 0.7× 43 0.5× 28 599

Countries citing papers authored by Karl Deacon

Since Specialization
Citations

This map shows the geographic impact of Karl Deacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Deacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Deacon more than expected).

Fields of papers citing papers by Karl Deacon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Deacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Deacon. The network helps show where Karl Deacon may publish in the future.

Co-authorship network of co-authors of Karl Deacon

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Deacon. A scholar is included among the top collaborators of Karl Deacon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Deacon. Karl Deacon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Deacon, Karl & Alan J. Knox. (2018). PINX1 and TERT Are Required for TNF-α–Induced Airway Smooth Muscle Chemokine Gene Expression. The Journal of Immunology. 200(4). 1283–1294. 11 indexed citations
2.
Deacon, Karl & Alan J. Knox. (2015). Human airway smooth muscle cells secrete amphiregulin via bradykinin/COX-2/PGE 2 , inducing COX-2, CXCL8, and VEGF expression in airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 309(3). L237–L249. 28 indexed citations
3.
Coward, William R., et al.. (2013). Epidermal growth factor receptor (EGFR) activation is required for TGFβ1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF). 42. 4892. 3 indexed citations
4.
Deacon, Karl, David Onion, Rajendra Kumari, Susan A. Watson, & Alan J. Knox. (2012). Elevated SP-1 Transcription Factor Expression and Activity Drives Basal and Hypoxia-induced Vascular Endothelial Growth Factor (VEGF) Expression in Non-Small Cell Lung Cancer. Journal of Biological Chemistry. 287(47). 39967–39981. 40 indexed citations
5.
Clifford, Rachel L., et al.. (2012). Ciclesonide inhibits TNFα- and IL-1β-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 302(8). L785–L792. 22 indexed citations
6.
Deacon, Karl & Alan J. Knox. (2010). Endothelin-1 (ET-1) Increases the Expression of Remodeling Genes in Vascular Smooth Muscle through Linked Calcium and cAMP Pathways. Journal of Biological Chemistry. 285(34). 25913–25927. 37 indexed citations
7.
Clarke, Deborah, Amy Sutcliffe, Karl Deacon, et al.. (2008). PKCβΙΙ Augments NF-κB-Dependent Transcription at the CCL11 Promoter via p300/CBP-Associated Factor Recruitment and Histone H4 Acetylation. The Journal of Immunology. 181(5). 3503–3514. 39 indexed citations
8.
Clifford, Rachel L., Karl Deacon, & Alan J. Knox. (2008). Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor β1. Journal of Biological Chemistry. 283(51). 35337–35353. 85 indexed citations
9.
Clarke, Damian, et al.. (2007). IL-1β, BK, and TGF-β1attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA. American Journal of Physiology-Lung Cellular and Molecular Physiology. 294(3). L553–L562. 22 indexed citations
10.
Mistry, Pratibha, Karl Deacon, Sharad Mistry, Jonathan L. Blank, & Rajni V. Patel. (2004). NF-κB Promotes Survival during Mitotic Cell Cycle Arrest. Journal of Biological Chemistry. 279(2). 1482–1490. 46 indexed citations
11.
Deacon, Karl, Pratibha Mistry, Jonathan Chernoff, Jonathan L. Blank, & R. M. Patel. (2003). p38 Mitogen-Activated Protein Kinase Mediates Cell Death and p21-Activated Kinase Mediates Cell Survival during Chemotherapeutic Drug-induced Mitotic Arrest. Molecular Biology of the Cell. 14(5). 2071–2087. 153 indexed citations
12.
Deacon, Karl & Jonathan L. Blank. (1999). MEK Kinase 3 Directly Activates MKK6 and MKK7, Specific Activators of the p38 and c-Jun NH2-terminal Kinases. Journal of Biological Chemistry. 274(23). 16604–16610. 82 indexed citations
13.
Deacon, Karl & Jonathan L. Blank. (1997). Characterization of the Mitogen-activated Protein Kinase Kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 Pathways Regulated by MEK Kinases 2 and 3. Journal of Biological Chemistry. 272(22). 14489–14496. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026